中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共100条,第1-10条 帮助

条数/页: 排序方式:
Structure-based drug discovery of novel fused- pyrazolone carboxamide derivatives as potent and selective AXL inhibitors 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4918-4933
作者:  
Fang, Feifei;  Dai, Yang;  Wang, Hao;  Ji, Yinchun;  Liang, Xuewu
  |  收藏  |  浏览/下载:4/0  |  提交时间:2024/01/26
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割
JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162
作者:  
Lai, Mengzhen;  Zhang, Tao;  Chen, Hao;  Song, Peiran;  Tong, Linjiang
  |  收藏  |  浏览/下载:77/0  |  提交时间:2023/04/10
Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 页码: 15
作者:  
Zhan, Zhengsheng;  Ji, Yinchun;  Su, Haixia;  Fang, Chen;  Peng, Xia
  |  收藏  |  浏览/下载:28/0  |  提交时间:2023/04/10
DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization 期刊论文  OAI收割
SCIENTIFIC REPORTS, 2022, 卷号: 12, 期号: 1, 页码: 15
作者:  
Zhang, Huiying;  Li, Bo;  Ding, Jingjuan;  Ye, Rong;  Xu, Zhijian
  |  收藏  |  浏览/下载:18/0  |  提交时间:2023/10/17
Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 22, 页码: 15374-15390
作者:  
Chan, Shingpan;  Zhang, Yunong;  Wang, Jie;  Yu, Qiuchun;  Peng, Xia
  |  收藏  |  浏览/下载:16/0  |  提交时间:2023/04/10
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文  OAI收割
THORACIC CANCER, 2022
作者:  
Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo
  |  收藏  |  浏览/下载:35/0  |  提交时间:2022/12/22
Coronarin A modulated hepatic glycogen synthesis and gluconeogenesis via inhibiting mTORC1/S6K1 signaling and ameliorated glucose homeostasis of diabetic mice 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 14
作者:  
Huang, Su-Ling;  Xie, Wei;  Ye, Yang-Liang;  Liu, Jia;  Qu, Hui
  |  收藏  |  浏览/下载:31/0  |  提交时间:2022/11/11
原肌球蛋白受体激酶(TRK)抑制剂的研究进展 期刊论文  OAI收割
有机化学, 2022, 卷号: 42, 期号: 7, 页码: 2055-2069
作者:  
杨竣喆;  许子超;  李淳朴;  程远征;  柳红
  |  收藏  |  浏览/下载:10/0  |  提交时间:2024/03/21
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2022
作者:  
Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
  |  收藏  |  浏览/下载:52/0  |  提交时间:2022/03/28
Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy 期刊论文  OAI收割
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 906, 页码: 8
作者:  
Xiao, Meng-Chao;  Qian, Hui;  Huang, Chen-Kai;  Zheng, Bai-Nan;  Yan, Fang-Zhi
  |  收藏  |  浏览/下载:65/0  |  提交时间:2021/11/04